Equities

Glenmark Pharmaceuticals Ltd

GLENMARK:NSI

Glenmark Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,649.80
  • Today's Change7.40 / 0.45%
  • Shares traded995.15k
  • 1 Year change+93.21%
  • Beta1.1527
Data delayed at least 15 minutes, as of Sep 19 2024 11:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income5,6928,68514,412
Depreciation/depletion6,3086,1134,867
Non-Cash items3,7908,6073,004
Cash taxes paid, supplemental10,4756,4055,584
Cash interest paid, supplemental5,1683,1152,505
Changes in working capital(20362)(17144)(11197)
Total cash from operations(4572)6,26111,087
INVESTING
Capital expenditures(9149)(6078)(7901)
Other investing and cash flow items, total54,7587934,568
Total cash from investing45,609(5285)(3333)
FINANCING
Financing cash flow items(5168)(4643)(3079)
Total cash dividends paid(1178)(1366)(927)
Issuance (retirement) of stock, net12010,119
Issuance (retirement) of debt, net(32728)5,234(11317)
Total cash from financing(39061)(775)(5205)
NET CHANGE IN CASH
Foreign exchange effects177124176
Net change in cash2,1523252,724
Net cash-begin balance/reserved for future use14,43014,10511,381
Net cash-end balance/reserved for future use16,58314,43014,105
SUPPLEMENTAL INCOME
Depreciation, supplemental6,3086,1134,867
Cash interest paid, supplemental5,1683,1152,505
Cash taxes paid, supplemental10,4756,4055,584
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.